Domača stranOPL • ASX
add
Opyl Ltd
Prejšnji trg. dan.
0,015 $
Dnevni razpon
0,015 $ - 0,015 $
Letni razpon
0,014 $ - 0,035 $
Tržna kapitalizacija
2,17 mio. AUD
Povprečni obseg
149,82 tis.
Razm. P/E
-
Dividendna donosnost
-
Primarna borza
ASX
Borzne novice
Finančni podatki
Izkaz poslovnega izida
Prihodek
Čisti dohodek
| (AUD) | jun. 2024info | Sprememba L/L |
|---|---|---|
Prihodek | 76,98 tis. | −53,11 % |
Stroški poslovanja | 421,40 tis. | 55,20 % |
Čisti dohodek | −927,04 tis. | −67,65 % |
Čista dobičkovnost prihodkov | −1,20 tis. | −257,51 % |
Earnings per share | — | — |
EBITDA | −909,06 tis. | −66,48 % |
Efektivna davčna stopnja | — | — |
Bilanca stanja
Skupna sredstva
Skupne obveznosti
| (AUD) | jun. 2024info | Sprememba L/L |
|---|---|---|
Denar. in kratkor. naložbe | 374,64 tis. | −17,27 % |
Skupna sredstva | 411,60 tis. | −41,99 % |
Skupne obveznosti | 501,76 tis. | −54,93 % |
Celoten lastniški kapital | −90,16 tis. | — |
Shares outstanding | 222,15 mio. | — |
Razmerje P/B | ∞ | — |
Donosnost sredstev | −556,44 % | — |
Donosnost kapitala | 2.540,24 % | — |
Denarni tok
Neto sprememba denarnih sredstev
| (AUD) | jun. 2024info | Sprememba L/L |
|---|---|---|
Čisti dohodek | −927,04 tis. | −67,65 % |
Denar iz dejavnosti | −738,29 tis. | −58,54 % |
Denar iz naložb | −8,86 tis. | −7.807,14 % |
Denar iz financiranja | 642,12 tis. | 72,83 % |
Neto sprememba denarnih sredstev | −105,03 tis. | −11,42 % |
Prost denarni tok | −171,58 tis. | 42,93 % |
Vizitka
Opyl is a Melbourne-based company listed on the Australian Securities Exchange that applies artificial intelligence to improving clinical trial efficiencies. The company has two key platforms: Opin a global clinical trial recruitment platform and service as well as TrialKey a Saas software as a service platform that predicts and designs optimized clinical trial protocols, reducing the risk of failure and improving a return on investment in new and emerging medicines, devices, and diagnostics..
Opyl is a rebrand and strategic realignment from a former company known as ShareRoot, a US-based martech platform that secured rights to user-generated content on social media, predominantly used by big brands that collaborated with influencers.
Before going public in 2016, ShareRoot had previously participated in 500 Startups batch 8 and raised a round of angel investing.
ShareRoot was rebranded to Opyl in 2020 to work on technology to support the health and life sciences sector. Wikipedia
Datum ustanovitve
2013
Spletno mesto
Zaposleni
3
